home / stock / xomap / xomap articles
Low-cost financing capitalizes on XOMA's $14 million acquisition of VABYSMO® (faricimab) royalties in 2021 Proceeds expected to be used...
EMERYVILLE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ:XOMA) ("XOMA" or the "Company") today announced its Board of Dir...
EMERYVILLE, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ:XOMA), the Biotech Royalty Aggregator, announced today Owen Hugh...
News, Short Squeeze, Breakout and More Instantly...
XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock Company Name:
XOMAP Stock Symbol:
NASDAQ Market:
XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock Website:
2024-07-02 09:00:25 ET XOMA Corp (XOMAP) declaring a stock dividend of $0.53906 per share on Ex-Date : July 03, 2024. Shareholders on record as of July 03, 2024 are eligible for the dividend. The payment date is scheduled for July 15, 2024, and the declaration was officially made on...
EMERYVILLE, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has received an $8.1 million milestone payment from Viracta Therapeutics, Inc., related to Day One Biopharmaceuticals’ recent sale of its Priority Revie...
2024-05-26 12:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...